The PRODIGY Trial
PRODIGY (PRediction of Opioid‐induced respiratory Depression In patients monitored by capnoGraphY) is a prospective, multi‐center, international cohort study to assess the potential for respiratory compromise (RC) risk assessment in patients receiving opioids on the hospital general care floor also examining the value of continuous capnography and oximetry monitoring.
-
Download Now
The PRODIGY Study at a Glance
-
Learn More
Infographic: Learn About the PRODIGY Study
-
3:16Watch VideoVideo: PRODIGY Animation
-
Download Now
Respiratory Compromise PRODIGY FAQ
-
Download NowComplimentary PRODIGY Risk Prediction Tool
-
55:27Watch VideoInterviews on Respiratory Compromise
Thought leaders discuss why they believe respiratory compromise is an important safety issue needing better solutions.
-
2:28Watch VideoVideo: Evidence Summary of PRODIGY Study
-
LOG IN TO LISTEN
PRODIGY Podcast
Dr. Ludwig Lin interviews Dr. Ashish Khanna on the PRODIGY study, awarded a Star Research Presentation at the SCCM conference.
-
Explore Remote Continuous Monitoring Solutions
Learn More -
Download NowWhite Paper: Who Are Your High Risk Respiratory Patients & How to Assess Them
-
2:25Watch VideoVideo: Evidence Summary PRODIGY Seeking Answers
-
Download NowCSM Khanna Seeking Answers from PRODIGY Clinical Summary
-
Download NowCost efficiency and patient safety
-
BACK TO RESPIRATORY COMPROMISE RESOURCES
VIEW ALL -
Loading More...
